Literature DB >> 27876610

Establishing reference intervals for hCG in postmenopausal women.

Khushbu K Patel1, Abraham J Qavi1, Karl G Hock1, Ann M Gronowski2.   

Abstract

BACKGROUND: Plasma concentrations of human chorionic gonadotropin (hCG) have been shown to increase with age due to pituitary secretion. We previously recommended that an hCG cutoff of 14.0IU/L be used for women ≥55years of age. However, it remains unknown whether concentrations >14.0IU/L can be expected in women with advanced age. Our objectives were to establish plasma hCG reference intervals and correlate follicle stimulating hormone (FSH) and hCG concentrations in postmenopausal females ≥55years.
METHODS: Residual plasma samples from 798 women ≥55years were utilized with 303, 269, and 226 samples belonging to the age groups 55-69, 70-84, and ≥85years, respectively. FSH and hCG were measured using the Abbott ARCHITECT. All positive hCG samples (hCG ≥5IU/L) were analyzed for potential heterophile antibody interference and 3 were excluded. Electronic medical records were reviewed and patients with malignancy were excluded.
RESULTS: 8% (56/666) of women age≥55years had plasma hCG ≥5IU/L. There were 19, 16, and 21 patients with hCG ≥5IU/L in the age groups 55-69, 70-84, and ≥85years, respectively. The highest hCG concentrations observed in each age group were: 55-69years maximum=11.7IU/L and 97.5th percentile=9.6IU/L; 70-84years maximum=18.09IU/L, 97.5th percentile=6.2IU/L; ≥85years maximum=11.1IU/L and 97.5th percentile=10.0IU/L, and the overall 97.5th percentile=8.5IU/L for all women ≥55years of age. Neither hCG nor FSH concentrations continued to increase with age in women ≥55years.
CONCLUSIONS: The prevalence of positive hCG in women ≥55years is 8%. This study confirms our previously recommended cutoff of 14IU/L for women ≥55years of age. In women ≥55years of age, FSH concentrations do not predict hCG concentrations.
Copyright © 2016 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27876610     DOI: 10.1016/j.clinbiochem.2016.11.017

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Pregnancy, malignancy or mother nature? Persistence of high hCG levels in a perimenopausal woman.

Authors:  Ayşe Y Demir; Ruben Ea Musson; Willem A Schöls; Jitze M Duk
Journal:  BMJ Case Rep       Date:  2019-01-03

2.  Postmenopausal pregnancy? Evaluation of elevated hCG in a 59-year-old woman.

Authors:  Mary Margaret Basham; Teresa Bryan
Journal:  BMJ Case Rep       Date:  2017-06-05

3.  The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.

Authors:  Akitoshi Takizawa; Koji Kawai; Takashi Kawahara; Takahiro Kojima; Satoru Maruyama; Nobuo Shinohara; Shusuke Akamatsu; Tomomi Kamba; Terukazu Nakamura; Osamu Ukimura; Ryosuke Jikuya; Takeshi Kishida; Kenichi Kakimoto; Kazuo Nishimura; Toru Harabayashi; Satoshi Nagamori; Shinichi Yamashita; Yoichi Arai; Yoshitomo Sawada; Noritoshi Sekido; Hidefumi Kinoshita; Tadashi Matsuda; Tohru Nakagawa; Yukio Homma; Hiroyuki Nishiyama
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-13       Impact factor: 4.553

4.  Exclusion of pregnancy in dialysis patients: diagnostic performance of human chorionic gonadotropin.

Authors:  Natalja Haninger-Vacariu; Harald Herkner; Matthias Lorenz; Marcus Säemann; Andreas Vychytil; Martin Jansen; Rodrig Marculescu; Reinhard Kramar; Gere Sunder-Plassmann; Alice Schmidt
Journal:  BMC Nephrol       Date:  2020-02-28       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.